These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28855206)

  • 1. HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1.
    Vandyke K; Zeissig MN; Hewett DR; Martin SK; Mrozik KM; Cheong CM; Diamond P; To LB; Gronthos S; Peet DJ; Croucher PI; Zannettino ACW
    Cancer Res; 2017 Oct; 77(20):5452-5463. PubMed ID: 28855206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells
    Zeissig MN; Hewett DR; Panagopoulos V; Mrozik KM; To LB; Croucher PI; Zannettino ACW; Vandyke K
    Haematologica; 2021 Dec; 106(12):3176-3187. PubMed ID: 33147936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.
    Martin SK; Diamond P; Williams SA; To LB; Peet DJ; Fujii N; Gronthos S; Harris AL; Zannettino AC
    Haematologica; 2010 May; 95(5):776-84. PubMed ID: 20015878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain.
    Knerlich-Lukoschus F; von der Ropp-Brenner B; Lucius R; Mehdorn HM; Held-Feindt J
    J Neurosurg Spine; 2011 May; 14(5):583-97. PubMed ID: 21332278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression of HIF-1alpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties.
    Ben-Shoshan J; Schwartz S; Luboshits G; Maysel-Auslender S; Barzelay A; Polak-Charcon S; Tzahor E; Barshack I; Barak A; Levkovitch-Verbin H; Keren G; George J
    Stem Cells; 2008 Oct; 26(10):2634-43. PubMed ID: 18687993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity.
    Trentin L; Miorin M; Facco M; Baesso I; Carraro S; Cabrelle A; Maschio N; Bortoli M; Binotto G; Piazza F; Adami F; Zambello R; Agostini C; Semenzato G
    Br J Haematol; 2007 Sep; 138(5):594-602. PubMed ID: 17686053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.
    Vande Broek I; Leleu X; Schots R; Facon T; Vanderkerken K; Van Camp B; Van Riet I
    Haematologica; 2006 Feb; 91(2):200-6. PubMed ID: 16461304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia stimulates CXCR4 signalling in ileal carcinoids.
    Arvidsson Y; Bergström A; Arvidsson L; Kristiansson E; Ahlman H; Nilsson O
    Endocr Relat Cancer; 2010 Jun; 17(2):303-16. PubMed ID: 20071457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.
    Beider K; Bitner H; Leiba M; Gutwein O; Koren-Michowitz M; Ostrovsky O; Abraham M; Wald H; Galun E; Peled A; Nagler A
    Oncotarget; 2014 Nov; 5(22):11283-96. PubMed ID: 25526031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Chemokine Receptor, CXCR4, Which Is Regulated by Hypoxia-Inducible Factor 2α, Is Crucial for Functional Endothelial Progenitor Cells Migration to Ischemic Tissue and Wound Repair.
    Tu TC; Nagano M; Yamashita T; Hamada H; Ohneda K; Kimura K; Ohneda O
    Stem Cells Dev; 2016 Feb; 25(3):266-76. PubMed ID: 26620723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between expression of chemokine receptor and curative effect of multiple myeloma].
    Pei RZ; Tang SH; Ma JX; Zhang PS; Liu XH; DU XH; Chen Z; Chen D; Sha KY; Cao JJ; Li SY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):73-5. PubMed ID: 21362225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss.
    Diamond P; Labrinidis A; Martin SK; Farrugia AN; Gronthos S; To LB; Fujii N; O'Loughlin PD; Evdokiou A; Zannettino AC
    J Bone Miner Res; 2009 Jul; 24(7):1150-61. PubMed ID: 19335218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
    Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
    Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-2α-ILK Is Involved in Mesenchymal Stromal Cell Angiogenesis in Multiple Myeloma Under Hypoxic Conditions.
    Zhang X; Xu Y; Liu H; Zhao P; Chen Y; Yue Z; Zhang Z; Wang X
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818764473. PubMed ID: 29656700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.
    García-Bernal D; Redondo-Muñoz J; Dios-Esponera A; Chèvre R; Bailón E; Garayoa M; Arellano-Sánchez N; Gutierrez NC; Hidalgo A; García-Pardo A; Teixidó J
    J Pathol; 2013 Jan; 229(1):36-48. PubMed ID: 22711564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.
    Zeissig MN; Hewett DR; Mrozik KM; Panagopoulos V; Wallington-Gates CT; Spencer A; Dold SM; Engelhardt M; Vandyke K; Zannettino ACW
    Leuk Res; 2024 Apr; 139():107469. PubMed ID: 38479337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients.
    Oliveira AM; Maria DA; Metzger M; Linardi C; Giorgi RR; Moura F; Martinez GA; Bydlowski SP; Novak EM
    Leuk Res; 2009 Jul; 33(7):970-3. PubMed ID: 18976811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
    Liu L; Yu Z; Cheng H; Mao X; Sui W; Deng S; Wei X; Lv J; Du C; Xu J; Huang W; Xia S; An G; Zhou W; Ma X; Cheng T; Qiu L; Hao M
    Sci Rep; 2020 Nov; 10(1):20508. PubMed ID: 33239656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.